InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: WeeZuhl post# 238947

Friday, 01/13/2017 9:41:13 AM

Friday, January 13, 2017 9:41:13 AM

Post# of 403564
I can appreciate it could be Purdue regarding patent royalty fees or Pfizer in the broad sense of exclusivity rights. I should have been more clear. Pfizer has no leg to stand on regarding patent rights regarding formulation. Clearly they do on exclusivity rights but only regarding Troxyca. Pfizer has no exclusivity rights regarding Embeda whatsoever any longer to my knowledge.


Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News